Noninvasive in vivo confocal microscopy (IVCM) detected signs of nerve damage in the cornea — the eye’s transparent outer layer…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
People with Fabry disease spend an average of six hours on activities related to a single treatment with an…
A new mutation in the GLA gene was identified as the cause of Fabry disease in two people who turned…
Family planning is the main event in a woman’s life that’s most affected by Fabry disease, while passing the…
Up to 20 years of treatment with agalsidase alfa slowed declines in kidney and heart function, and extended…
Researchers discovered new mutations in the GLA gene, the underlying cause of Fabry disease, but noted that all of…
Mild to moderate cerebrovascular disease, which occurs when blood flow in the brain is impaired, is a characteristic brain signature…
Fabry disease is underdiagnosed across different minority ethnic groups in the U.K., a study suggests. Despite making up about…
Five years after receiving the experimental Fabry disease gene therapy AVR-RD-01, kidney function in all five participants remains relatively…
Women severely affected by Fabry disease and treated with enzyme replacement therapy (ERT) and untreated women with less…